相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling
H. Hampel et al.
CLIMACTERIC (2017)
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2016)
Increased CSF neurogranin concentration is specific to Alzheimer disease
Henrietta Wellington et al.
NEUROLOGY (2016)
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
Julia Remnestal et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh et al.
JAMA NEUROLOGY (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
Hlin Kvartsberg et al.
ALZHEIMERS & DEMENTIA (2015)
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
Ann De Vos et al.
ALZHEIMERS & DEMENTIA (2015)
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease
Erik Portelius et al.
BRAIN (2015)
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
Hlin Kvartsberg et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I. Kester et al.
JAMA NEUROLOGY (2015)
Is synaptic loss a unique hallmark of Alzheimer's disease?
Stephen W. Scheff et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Translational biomarker discovery in clinical metabolomics: an introductory tutorial
Jianguo Xia et al.
METABOLOMICS (2013)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
Simone Lista et al.
BIOMARKERS IN MEDICINE (2011)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Present and the Future
Roberta Ghidoni et al.
NEURODEGENERATIVE DISEASES (2011)
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell et al.
BRAIN RESEARCH (2010)
Neurogranin, a Link Between Calcium/Calmodulin and Protein Kinase C Signaling in Synaptic Plasticity
F. Javier Diez-Guerra
IUBMB LIFE (2010)
Neurogranin enhances synaptic strength through its interaction with calmodulin
Ling Zhong et al.
EMBO JOURNAL (2009)
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
John Hardy
JOURNAL OF NEUROCHEMISTRY (2009)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff et al.
NEUROLOGY (2007)
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
PH Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
H Vanderstichele et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid:: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen et al.
NEUROSCIENCE LETTERS (2000)
分享论文
